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Background:
Magnetic iron oxide nanoparticles (MNP) have the potential for use as a multimodal cancer therapy agent due to their ability to carry
and release anticancer drugs, potential as radiation sensitizing agents, as well as creating localized heat when exposed to an
alternating magnetic field (AMF). [1, 2] The size and coating on the MNP, as well as the method of delivery, affects the cellular uptake
of MNP.[3] The mechanism for the uptake and distribution within cells is not fully understood. Optimization of targeted cellular
uptake is critical if magnetically induced hyperthermia is to continued to be developed as a viable clinical cancer therapy.
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Figure 1: Left: Transmission electron microscopy (TEM) of tumor
cell uptake of MNP. This TEM image MNP inside of vesicles
within a murine adenocarcinoma cell (arrows). The cell’s nucleus
(triangle) is shown adjacent to the nanoparticle collections.[3]
Right: MTGB cells incubated with MNP for 48 hours (in vitro).
Prussian Blue stain indicates MNP (iron). Significant variation in
MNP concentration appears to exist within the cell population.
.
Goal:
We propose to develop a method to separate cells based on intracellular MNP concentration which will then allow us to further study
and optimize cellular uptake in tumor cells.
Significance:
Current methods of MNP quantification consider the average iron concentration in a bulk sample (millions of cells), or are
qualitative/2D methods which do not provide absolute iron values. By developing a method which separates living cells, we will be
able better examine the mechanisms responsible for intracellular uptake. In addition, we will be able to quantify the variation of MNP
concentration cell to cell which histology suggests exists.
Methods of validation:
Transmission electron microscope (TEM): Characterization of particle uptake and endosome size.
Inductively coupled plasma mass spectroscopy(ICP-MS): Quantification of the iron content present in the cells (average value).
Histopathological analysis: Prussian blue staining to identify relative iron content in cells.
Basic experimental outline for future experiments using proposed separation method:
We propose to use a solenoid which will create a magnetic field when current passes through the solenoid. The magnetic field created
will be strong enough to separate the cells based on their intracellular MNP concentration. The following formula can be used to
calculate the magnetic field.
B=(µNI)/ L
Where B is the magnetic field strength, N is the number of turns in the solenoid, I is the current and L is the length of the solenoid.
Cells will be cultured under optimum conditions and after 80% confluency is reached, the cells will be incubated with MNPs for 48
hours.
Variables to be explored in future work:
We intend to study the cell fractions obtained after the separation and study the gene expression profile of the key genes, the role of
hypoxia during MNP uptake by cells, cell cycle analysis of the fractions and the metabolic profile of the cells. Variation in particle
material and size will also be considered.
